Sat, Dec 27, 2014, 3:24 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • dinepat203 dinepat203 Oct 24, 2012 6:09 AM Flag

    Approval is 100% as Cramer Endorses on CNBC but why price is 30% down in 5 Days?

    Still, Cramer believes the FDA will approve Kynamro when they make their final decision at the end of January.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • So what ! Darkster told us that 5 years back. "Not a dime to the bottom line with limited approval." Where have you been ? Darkster had this down pat !

    • Isis CEO, Dr. Stanley Crooke, explained that the study showed no increased cancer risk in human beings and the small findings that did surface were "blown out of proportion." While there are some concerns about the liver, the competing drugs showed far more risk in this area. Dr. Crooke pointed out the Kynamro has been studied extensively and is favored by lipid experts. "It wasn't a question of facts," said Dr. Crooke, "It was a question of interpretation of data."

      Sentiment: Strong Buy

 
ISIS
63.65+4.16(+6.99%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Prothena Corporation plc
NASDAQFri, Dec 26, 2014 4:00 PM EST
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST